Submitted by Anonymous (not verified) on 23 February 2026 - 15:50
Human medicines European public assessment report (EPAR): Emblaveo, aztreonam,avibactam, Date of authorisation: 22/04/2024, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Emblaveo, aztreonam,avibactam, Date of authorisation: 22/04/2024, Revision: 3, Status: Authorised